Cerus Corp
Company Profile
Business description
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.
Contact
1220 Concord Avenue
Suite 600
Concord CA 94520
USAT: +1 925 288-6000
E: ir@cerus.com
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2024
Employees
280
Cerus Corp News & Analysis
funds
No room on the ARK?
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
---|---|---|---|
All Ordinaries | 8,316.70 | 53.10 | 0.64% |
CAC 40 | 7,630.95 | 10.00 | -0.13% |
DAX 40 | 18,906.92 | 5.65 | -0.03% |
Dow JONES (US) | 41,563.08 | 228.03 | 0.55% |
FTSE 100 | 8,376.63 | 3.01 | -0.04% |
HKSE | 17,989.07 | 202.75 | 1.14% |
NASDAQ | 17,713.62 | 197.19 | 1.13% |
Nikkei 225 | 38,647.75 | 285.22 | 0.74% |
NZX 50 Index | 12,447.68 | 94.07 | 0.76% |
S&P 500 | 5,648.40 | 56.44 | 1.01% |
S&P/ASX 200 | 8,091.90 | 46.80 | 0.58% |
SSE Composite Index | 2,842.21 | 19.11 | 0.68% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
---|---|---|---|
Aurizon Holdings Ltd AZJ | 3.38 | 0.00 | 0.00% |
Latin Resources Ltd LRS | 0.20 | 0.01 | -2.44% |
Red 5 Ltd RED | 0.34 | 0.02 | 6.25% |
Droneshield Ltd DRO | 1.33 | 0.09 | 7.29% |
Mesoblast Ltd MSB | 1.03 | 0.08 | 8.42% |
Spartan Resources Ltd SPR | 1.46 | 0.16 | 12.36% |
Telstra Group Ltd TLS | 3.93 | 0.02 | 0.51% |
Pilbara Minerals Ltd PLS | 2.97 | 0.06 | 2.06% |
Appen Ltd APX | 1.00 | 0.22 | -17.70% |
South32 Ltd S32 | 3.14 | 0.04 | 1.29% |